Increased saturation of the fatty acids in the sn-2 position of phospholipids reduces cholesterol crystallization in model biles

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1390, Issue 3, 1998, Pages 293-300

  Ringel, Yehuda ^a,b   Sömjen, Giora J ^a,b   Konikoff, Fred M ^a,b   Rosenberg, Ruth ^a,b   Gilat, Tuvia ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cholesterol crystallization; Fatty acyl saturation; Model bile; Phospholipid species

Indexed keywords

PHOSPHOLIPID;

ARTICLE; CHEMICAL STRUCTURE; CHOLESTEROL STONE; CRYSTALLIZATION; FATTY ACID DESATURATION; HUMAN; LIPID COMPOSITION; MEMBRANE STRUCTURE; MICROSCOPY; MODEL; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

BILE; CHOLESTEROL; CRYSTALLIZATION; FATTY ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; SPECTROPHOTOMETRY; TIME FACTORS; ULTRACENTRIFUGATION;

EID: 0344404178     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(97)00192-6     Document Type: Article

References (19)

1. Danzinger R.G., Hofmann A.F., Schoenfield L.J., Thistle J.L. Dissolution of cholesterol gallstones by chenodeoxycholic acid. New Engl. J. Med. 286:1972;1-8.
2. Hofmann A.F., Thistle J.L., Klein P.D., Szczepanik P.A., Yu P.Y.S. Chenotherapy for gallstone dissolution II. Induced changes in bile composition and gallstone response. J.A.M.A. 239:1978;1138-1144.
3. Jüngst D., Brenner G., Pratschke E., Paumgartner G. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. J. Hepatol. 8:1989;1-6.
4. Loria P., Carulli N., Medici G., Menozzi D., Salvioli G., Bertolotti M., Montanari M. Effect of ursocholic acid on bile lipid secretion and composition. Gastroenterology. 90:1986;865-874.
5. Marcus S.N., Heaton K.W. Deoxycholic acid and the pathogenesis of gallstones. Gut. 29:1988;522-533.
6. Hofmann A.F. Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand. J. Gastroenterol. 29:1994;1-15.
7. Cohen B.I., Hofmann A.F., Mosbach E.H., Stenger R.J., Rotschild M.A., Hagey L.R., Yoon Y.B. Differing effects of norursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit. Gastroenterology. 91:1986;189-197.
8. Robins S.J., Fasulo J.M., Robins V.F., Patton G.M. Utilization of different fatty acids for hepatic and biliary phosphatidylcholine formation and the effect of changes in phosphatidylcholine molecular species on biliary lipid secretion. J. Lipid Res. 32:1991;985-992.
9. Jüngst D., Lang T., Huber P., Lange V., Paumgartner G. Effect of phospholipids and bile acids on cholesterol nucleation time and vesicular/micellar cholesterol in gallbladder bile of patients with cholesterol stones. J. Lipid Res. 34:1993;1457-1464.
10. Halpern Z., Moshkowitz M., Laufer H., Peled Y., Gilat T. Effect of phospholipids and their molecular species on cholesterol solubility and nucleation in human and model biles. Gut. 34:1993;110-115.
11. Tao S., Tazuma S., Kajiyama G. Fatty acid composition of lecithin is a key factor in bile metastability in supersaturated model bile systems. Biochim. Biophys. Acta. 1167:1993;142-146.
12. Tazuma S., Ochi H., Teramen K., Yamashita Y., Horikawa K., Miura H., Hirano N., Sasaki M., Aihara N., Hatsushika S. Degree of fatty acyl chain unsaturation in biliary lecithin dictates cholesterol nucleation and crystal growth. Biochim. Biophys. Acta. 1215:1994;74-78.
13. Pope J.L. Crystallization of sodium taurocholate. J. Lipid Res. 8:1967;146-147.
14. Holan K.R., Holzbach R.T., Hermann R.E., Cooperman A.M., Claffey W.J. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology. 77:1979;611-617.
15. Sömjen G.J., Ringel Y., Konikoff F.M., Rosenberg R., Gilat T. A new method for the rapid measurement of cholesterol crystallization in model biles using a spectrophotometric microplate reader. J. Lipid Res. 38:1997;165-169.
16. Sömjen G.J., Gilat T. A non-micellar mode of cholesterol transport in human bile. FEBS Lett. 156:1983;265-268.
17. Konikoff F.M., Laufer H., Messer G., Gilat T. Monitoring cholesterol crystallization from lithogenic model bile by time - lapse density gradient ultracentrifugation. J. Hepatol. 26:1996;703-710.
18. Konikoff F.M., Carey M.C. Cholesterol crystallization from a dilute bile salt-rich model bile. J. Crystal Growth. 144:1994;79-86.
19. Konikoff F.M., Cohen D.E., Carey M.C. Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt-rich model bile. J. Lipid Res. 35:1994;60-70.